Coming Soon

In the wake of the Supreme Court ruling last week that invalidated patents on isolated gene sequences held by Myriad Genetics, a number of companies are jumping in to offer BRCA1 and BRCA2 testing. Pharmacogenomics Reporter notes that Ambry Genetics, GeneDx, Gene by Gene, Pathway Genomics, and the University of Washington have said that they will be launching BRCA gene tests.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: gene fusion in premature ovarian failure, population patterns in the Franciscana dolphin, and more.

A National Science Foundation-funded project aims to give researchers access to a network many times faster than the Internet.

Bioethicists weigh the idea of charging patients to take part in clinical research, coming down against the approach.

Cornell's Christopher Mason and his colleagues correct their New York City microbiome study to emphasize "the difference between matching fragments of DNA from a species and a pathogen."